|
|
|
Prolixin advertisement, 1982. Hospital & Community Psychiatry, Vol. 33, No. 9. Break the web of noncompliance with Prolixin Decanoate® Fluphenazine Decanoate Injection Noncompliance rates in schizophrenic outpatient populations range from 24 to 63 percent,(1) with studies suggesting a relapse-readmission rate of approximately 40 to 50 percent.(2) Consequently, these patients face progressive deterioration and increasing problems in rehabilitation. However, repeated relapses and their adverse consequences "...may be preventable by administration of long-acting injectable... fluphenazine decanoate."(3) Prolixin Decanoate -- an excellent tool to help you combat noncompliance in the chronic schizophrenic -- delivers medication as prescribed -- with a duration of action ranging from 14 to 28 days. The benefits -- reduced anxiety for patient, family, employer -- patient convenience -- savings in administration time and costs for outpatient treatment centers. Prolixin Decanoate -- keystone in Community Mental Health Center programs -- can help you maintain the noncompliant schizophrenic population as outpatients, not inpatients. 1. Van Putten T: Arch Gen Psychiat 31:67-72, 1974. 2. Imlah NW: Psychiatr Ann 13:22-32, 1973. 3. Gregory I, Smeltzer D: Psychiatry: Essentials of Clinical Practice, Boston, Little Brown & Co., 1977 p. 185. PROLIXIN DECANOATE® Fluphenazine Decanoate Injection ~ long-acting therapy for long-term maintenance. See following page for brief summary. © 1982 E. R. Squibb & Sons, Inc. |